Head And Neck Cancers

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of a cohort study.

Frequent daily coffee and tea drinkers are at lower risk for a variety of head and neck cancers, as well as mouth and throat-related cancers, according to data published in Cancer.

Spiritual beliefs and lack of trust in clinical research may influence Black individuals’ decisions about whether to participate in cancer trials, according to findings presented at American Society for Radiation Oncology Annual Meeting.

Researchers have found evidence that the contents of an individual’s oral microbiome may be associated with their risk for head and neck cancers.

The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.

Men vaccinated for HPV less frequently developed all related cancers, particularly head and neck cancers, according to findings scheduled for presentation at ASCO Annual Meeting.

A National Comprehensive Cancer Network Annual Conference plenary session examined the impact of drug shortages on oncology care, as well as potential solutions.

A personalized cancer vaccine produced T-cell responses in certain patients with head and neck squamous cell carcinoma, according to results from a randomized study presented at American Association for Cancer Research Annual Meeting.

As a 10-year-old in Nashville, Tennessee, Ashley C. Woods, MD, watched her grandmother avoid medical treatment for metastatic lung cancer until it was too late.

A yoga-based intervention provided beneficial supportive care among a cohort of patients undergoing radiotherapy for head and neck cancer and their caregivers, according to study results.